Literature DB >> 16985767

Improving the Safety of TURP.

C G Roehrborn.   

Abstract

Year:  2000        PMID： 16985767      PMCID： PMC1476133     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  8 in total

1.  Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia.

Authors:  A D'Addessi; V Perilli; R Ranieri; L Sollazzi; M A Crea; M Racioppi; A Alcini; E Alcini
Journal:  Scand J Urol Nephrol       Date:  1999-06

2.  Elevated mortality following transurethral resection of the prostate for benign hypertrophy! But why?

Authors:  T F Andersen; H Brønnum-Hansen; T Sejr; C Roepstorff
Journal:  Med Care       Date:  1990-10       Impact factor: 2.983

3.  Haemodynamic evidence for cardiac stress during transurethral prostatectomy.

Authors:  J W Evans; M Singer; C R Chapple; N Macartney; J M Walker; E J Milroy
Journal:  BMJ       Date:  1992-03-14

4.  Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis.

Authors:  D J Malenka; N Roos; E S Fisher; D McLerran; F S Whaley; M J Barry; R Bruskewitz; J E Wennberg
Journal:  J Urol       Date:  1990-08       Impact factor: 7.450

5.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

6.  Blood ammonia levels after intravenous infusion of glycine solution with and without ethanol.

Authors:  R G Hahn; L Sandfeldt
Journal:  Scand J Urol Nephrol       Date:  1999-08

7.  Problems of comorbidity in mortality after prostatectomy.

Authors:  J Concato; R I Horwitz; A R Feinstein; J G Elmore; S F Schiff
Journal:  JAMA       Date:  1992-02-26       Impact factor: 56.272

8.  Double-blind randomized study of symptoms associated with absorption of glycine 1.5% or mannitol 3% during transurethral resection of the prostate.

Authors:  R G Hahn; L Sandfeldt; C R Nyman
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.